Asia-focused venture capital firm Vickers Venture Partners said it has received USD 200 million in commitments for its USD 500 million fund—the sixth one managed by the firm.
“With Fund VI, we are extremely excited to continue investing globally in deep, disruptive technologies that are creating solutions that are more inclusive and sustainable for societies around the world,” Vickers chairman Finian Tan said.
Founded in 2005, the VC firm focuses on early-stage investments in Asia and beyond, covering life sciences, technology, media, telecommunications, as well as consumer and financial services.
One of its most recent investments include UK-based biotech company Emergex, which raised USD 11 million in a Series A funding round earlier this year. The startup is trying to develop safe and effective vaccinations against COVID-19 and other prevalent infectious diseases.
Vickers has also backed Singaporean fintech startup MatchMove, which is currently valued at about USD 300 million. Other portfolio companies include Samumed, Snapcart, M-Daq, and the Asian Food Channel, among others.
In October 2017, the company raised USD 230 million for its Fund V to invest in startups globally, with a focus on deep-tech and impact investments in emerging markets.
“Fund IV and V have a projected return of 10 times, and we expect Fund VI to follow in the footsteps,” Tan told Reuters.
Vickers is headquartered in Singapore, with offices in Shanghai, Hong Kong, New York, San Diego, Silicon Valley, and London.
This article first appeared in Tech in Asia.